Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-09-051317
Filing Date
2009-08-24
Accepted
2009-08-24 17:11:07
Documents
7

Document Format Files

Seq Description Document Type Size
1 424B3 a09-20816_1424b3.htm 424B3 8166874
2 GRAPHIC g208161bgi001.jpg GRAPHIC 4266
3 GRAPHIC g208161bgi002.gif GRAPHIC 2601
4 GRAPHIC g208161bii001.jpg GRAPHIC 6497
5 GRAPHIC g208161bei001.jpg GRAPHIC 4276
6 GRAPHIC g208161bei002.jpg GRAPHIC 6497
7 GRAPHIC g208161bei003.gif GRAPHIC 2577
  Complete submission text file 0001104659-09-051317.txt   8206072
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-161181 | Film No.: 091031801
SIC: 2836 Biological Products, (No Diagnostic Substances)